Endothelin-1 induces the expression of C-reactive protein in rat vascular smooth muscle cells

Biochem Biophys Res Commun. 2009 Nov 20;389(3):537-42. doi: 10.1016/j.bbrc.2009.09.023. Epub 2009 Sep 11.

Abstract

Numerous studies have shown that both vasoconstrictive peptide endothelin-1 (ET-1) and inflammatory marker C-reactive protein (CRP) are implicated in the inflammatory process of atherosclerosis. The purpose of the present study was to observe effect of ET-1 on CRP production and the molecular mechanisms in rat vascular smooth muscle cells (VSMCs). The results showed that ET-1 was capable of stimulating VSMCs to produce CRP both in protein and in mRNA levels in vitro and in vivo. ET(A) receptor antagonist BQ123, but not ET(B) receptor antagonist BQ788, inhibited CRP production in VSMCs. In addition, ET-1 was able to elicit reactive oxygen species (ROS) generation and mitogen-activated protein kinase (MAPK) activation, and antioxidant pyrrolidine dithiocarbamate and p38MAPK inhibitor SB203580 inhibited ET-1-induced CRP expression. The results demonstrate that ET-1 induces CPR production in VSMCs via ET(A) receptor followed by ROS and MAPK signal pathway, which may contribute to better understanding of the role of ET-1 in inflammatory activation of the vessel wall during atherogenesis.

MeSH terms

  • Animals
  • Atherosclerosis / metabolism
  • C-Reactive Protein / biosynthesis*
  • C-Reactive Protein / genetics
  • Cells, Cultured
  • Endothelin A Receptor Antagonists
  • Endothelin-1 / pharmacology
  • Endothelin-1 / physiology*
  • Muscle, Smooth, Vascular / drug effects
  • Muscle, Smooth, Vascular / metabolism*
  • Peptides, Cyclic / pharmacology
  • Rats
  • Reactive Oxygen Species / metabolism
  • Receptor, Endothelin A / metabolism
  • p38 Mitogen-Activated Protein Kinases / metabolism

Substances

  • Endothelin A Receptor Antagonists
  • Endothelin-1
  • Peptides, Cyclic
  • Reactive Oxygen Species
  • Receptor, Endothelin A
  • C-Reactive Protein
  • p38 Mitogen-Activated Protein Kinases
  • cyclo(Trp-Asp-Pro-Val-Leu)